Lamivudine or emtricitabine (XTC)/protease inhibitor dual therapy as a harm-reduction strategy in patients with tenofovir-related renal toxicity: A case–control study

Author: Rossotti Roberto   Moioli Maria Cristina   Chianura Leonardo   Errante Isabella   Orcese Carloandrea   Orso Maurizio   Schiantarelli Clara   Schlacht Irene   Travi Giovanna   Vigo Beniamino   Villa Maria Riccarda   Volonterio Alberto   Puoti Massimo  

Publisher: Informa Healthcare

ISSN: 0036-5548

Source: Scandinavian Journal of Infectious Diseases, Vol.44, Iss.11, 2012-11, pp. : 879-883

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content